Background
==========

Hypertension affects about one quarter of adults in industrialized countries \[[@B1]\] and carries a substantial burden of risk for cardiovascular disease (CVD), kidney disease, and death \[[@B2]\]. Increased arterial stiffness is a key factor in the pathogenesis of hypertension in older people and it contributes to the development of hypertensive target organ damage, CVD, and death \[[@B3]-[@B5]\]. Substantial heritability of blood pressure \[[@B6]\] and arterial stiffness \[[@B7]\]), as measured by arterial tonometry, points to genetic contributions to these cardiovascular phenotypes.

The search for genetic variants contributing to hypertension and arterial stiffness has focused on complementary approaches: linkage applied to rare Mendelian blood pressure disorders and to large family-based studies to identify positional candidate genes, and the study of biologically plausible candidate genes selected by virtue of their role in blood pressure regulation or vascular properties. A great deal is known about mutations responsible for Mendelian blood pressure disorders \[[@B8]\], but neither these rare variants nor more common variants in these genes account for substantial blood pressure variation in the general population. Similarly, although numerous linkage \[[@B9]\] and candidate gene association studies \[[@B10]\] have been conducted, there is a paucity of evidence that common genetic variation contributes to alterations in blood pressure or arterial stiffness in the general population.

Genome-wide association offers the opportunity to conduct analysis of common genetic variants unconstrained by prior knowledge of biological pathways in relation to phenotypes of interest. This approach succeeded in identifying the association of complement factor H with age-related macular degeneration \[[@B11]\]. The Framingham Heart Study, which enrolled participants without regard to phenotype status, provides a setting for a genome-wide association study in a community-based sample in which selection bias is inherently low. In addition, because of the familial structure of the study, it also provides an opportunity to use genome-wide SNP data for family based association testing (FBAT) and linkage analyses.

In this report we provide results of a genome-wide association study of blood pressure and arterial stiffness, including results of generalized estimating equation (GEE) association testing, FBAT, and linkage, as well as a summary of associations of these phenotypes with candidate genes in the renin-angiotensin-aldosterone pathways.

Methods
=======

Study sample
------------

The Framingham Heart Study began in 1948 when 5209 men and women from Framingham, Mass, who were between 28 and 62 years of age were recruited to participate in an observational study \[[@B12]\]. Subjects underwent a medical history, physician-administered physical examination including blood pressure measurement, laboratory tests, and electrocardiography. Examinations have been repeated every 2 years. In 1971, 5124 offspring and spouses of offspring of original participants were recruited into the Framingham Offspring Cohort \[[@B13]\]. The offspring cohort was reexamined approximately every 4 years, except for an 8 year interval between their initial and second visit. All subjects gave written informed consent before each clinic visit, and the examination protocol was approved by the Institutional Review Board at Boston Medical Center (Boston, Mass).

Blood pressure phenotypes
-------------------------

At each clinic visit, the examining physician measured the systolic and diastolic BP in the left arm using a mercury column sphygmomanometer. BP was measured twice at each visit, with the exception of the first Offspring Cohort clinic visit, when it was measured once in about half the participants. Systolic and diastolic pressures were determined by the first and fifth Korotkoff sounds, respectively, and the two BP measurements were averaged to derive the systolic and diastolic pressures for that examination.

Examination cycles for the two cohorts were overlaid temporally as follows \[offspring cohort/original cohort (earliest - latest year)\]: examination 1/examination 12 (1971--1975), examination 2/examination 16 (1979--1983), examination 3/examination 18 (1983--1987), examination 4/examination 20 (1986--1991), examination 5/examination 22 (1990--1995), examination 6/examination 24 (1995--1998) and examination 7/examination 26 (1998--2001). Referring to offspring cycle numbers, the six BP phenotypes analyzed for this investigation were residuals for SBP and DBP at Examination 1, at Examination 7, and average of residuals from available Examinations 1 to 7. BP was imputed for treated observations as previously described \[[@B6]\]. No adjustment was made for untreated observations, which constituted the vast majority of BP values. Systolic and diastolic BP phenotypes were analyzed independently. Residuals were obtained from cohort- and examination-specific regression models accounting for sex, age and BMI; for DBP, age-squared was added. For inclusion in long-term BP analyses, each participant had to have BP measured on at least three examinations over a period of 12 years or more.

Arterial stiffness phenotypes
-----------------------------

Arterial tonometry for assessment of arterial stiffness was conducted on Offspring Cohort participants attending their 7th clinic examination. Five primary tonometry phenotypes were analyzed: carotid-femoral and carotid-brachial pulse wave velocity, forward and reflected pressure wave amplitude, and mean arterial pressure. Tonometry was performed in the supine position after 5 minutes of rest. Arterial tonometry with simultaneous ECG recording was obtained from brachial, radial, femoral and carotid arteries using a commercially available tonometer (SPT-301, Millar Instruments, Houston, TX). Carotid-brachial, carotid-radial and carotid-femoral PWV were calculated as previously described \[[@B14]\]. Mean arterial pressure was calculated from the planimetered brachial arterial tracing after calibration to the brachial blood pressure, which was obtained by an oscillometric device. Forward pressure wave amplitude was defined as the difference between pressure at the waveform foot and pressure at the first systolic inflection point or peak of the carotid pressure waveform; reflected pressure wave amplitude was defined as the difference between the central systolic pressure and the pressure at the forward wave peak. Sex-specific regressions were conducted for each tonometry phenotype with the following covariates: age, age^2^, height, weight, to generate sex-specific residuals.

Genotyping methods
------------------

Details of the genotyping methods are available in the Executive Summary \[[@B15]\]. Briefly, 112990 autosomal SNPs on the Affymetrix 100K chip were genotyped in the Boston University School of Medicine Genetics Laboratory on the Framingham Heart Study family plate set. SNPs were excluded for the following reasons: minor allele frequency \<10% (n = 38062); call rate \<80% (n = 2346); Hardy Weinberg equilibrium p value \< 0.001 (n = 1595), leaving 70,987 SNPs available for analysis.

Statistical methods
-------------------

Standardized multivariable-adjusted blood pressure and tonometry residuals were generated as described above. Table [1](#T1){ref-type="table"} lists the covariates used for each phenotype. As described in the Executive Summary \[[@B15]\], we conducted association testing using family based association testing (FBAT), and generalized estimating equations (GEE) applied to the additive genetic effects model. In secondary analyses that used the GEE general genetic effects model, which is more sensitive to recessive genetic effects, to be more conservative, we limited analyses to two phenotypes: long-term SBP and long-term DBP, and we limited eligible SNPs to those with a minor allele frequency \>= 0.20 and Hardy-Weinberg equilibrium p value \>= 0.05. The software package Merlin \[[@B16]\] was used to compute exact identity by descent linkage probabilities for allele sharing, and linkage analysis by variance component method was carried out SOLAR using 11,200 SNPs and STRs. Heritability was estimated using variance-components methods (SOLAR). For BP, 2155 study participants were used for examination 1 SBP and DBP, 1479 for examination 7, and 2009 for long-term average; 770 individuals were used in heritability analysis of arterial stiffness phenotypes.

###### 

Phenotype List

                                     Exam cycle/s                                                                                 
  ---------------------------- ----- -------------------- ------------------------------------------ ---------------------------- ----------------------------------
                               N\*   Offspring            Cohort                                     Adjustment                   Covariates
                                                                                                                                  
  **Primary Phenotypes**                                                                                                          
                                                                                                                                  
  Blood Pressure                                                                                                                  
                                                                                                                                  
  SBP 1                        2     1                    12                                         Age and sex, multivariable   Cohort, sex, age, BMI
  SBP 7                        2     7                    26                                         Age and sex, multivariable   Cohort, sex, age, BMI
  SBP 1--7                     2     Mean of exams 1--7   Mean of exams 12, 16, 18, 20, 22, 24, 26   Age and sex, multivariable   Cohort, sex, age, BMI
  DBP 1                        2     1                    12                                         Age and sex, multivariable   Cohort, sex, age, BMI
  DBP 7                        2     7                    26                                         Age and sex, multivariable   Cohort, sex, age, BMI
  DBP 1--7                     2     Mean of exams 1--7   Mean of exams 12, 16, 18, 20, 22, 24, 26   Age and sex, multivariable   Cohort, sex, age, BMI
                                                                                                                                  
  Tonometry                                                                                                                       
                                                                                                                                  
  Carotid-femoral PWV          2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  Carotid-brachial PWV         2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  Forward pressure wave        2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  Reflected pressure wave      2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  Mean arterial pressure       2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
                                                                                                                                  
  **Secondary Phenotypes\^**                                                                                                      
                                                                                                                                  
  Blood Pressure                                                                                                                  
                                                                                                                                  
  DBP 2                        2     2                    16                                         Age and sex, multivariable   Cohort, sex, age, BMI
  DBP 3                        2     3                    18                                         Age and sex, multivariable   Cohort, sex, age, BMI
  DBP 4                        2     4                    20                                         Age and sex, multivariable   Cohort, sex, age, BMI
  DBP 5                        2     5                    22                                         Age and sex, multivariable   Cohort, sex, age, BMI
  DBP 6                        2     6                    24                                         Age and sex, multivariable   Cohort, sex, age, BMI
  SBP 2                        2     2                    16                                         Age and sex, multivariable   Cohort, sex, age, BMI
  SBP 3                        2     3                    18                                         Age and sex, multivariable   Cohort, sex, age, BMI
  SBP4                         2     4                    20                                         Age and sex, multivariable   Cohort, sex, age, BMI
  SBP 5                        2     5                    22                                         Age and sex, multivariable   Cohort, sex, age, BMI
  SBP 6                        2     6                    24                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 1                         2     1                    12                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 2                         2     2                    16                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 3                         2     3                    18                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 4                         2     4                    20                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 5                         2     5                    22                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 6                         2     6                    24                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 7                         2     7                    26                                         Age and sex, multivariable   Cohort, sex, age, BMI
  PP 1--7                      2     Mean of exams 1--7   Mean of exams 12, 16, 18, 20, 22, 24, 26   Age and sex, multivariable   Cohort, sex, age, BMI
                                                                                                                                  
  Tonometry                                                                                                                       
                                                                                                                                  
  1/CF-PWV                     2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  AI                           2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  CPP                          2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  CR-PWV                       2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  DBP-osc                      2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  PA-1                         2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  PA-2                         2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  PP-osc                       2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  RWTT                         2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight
  SBP-osc                      2     7                    Not included                               Age and sex, multivariable   Sex, age, age\^2, height, weight

\*n = number of phenotypes analyzed

\^Association results for primary and secondary phenotypes are available on the worldwide web at: <http://web.ncbi.nlm.nih.gov/projects/gap/framingham/cgi-bin/study.cgi?id=phs000007>

AI = augmentation index; CPP = central pulse pressure; CB-PWV = carotid brachial pulse wave velocity; CF-PWV = carotid-femoral pulse wave velocity; CR-PWV = carotid-radial pulse wave velocity; DBP = diastolic blood pressure; DBP-osc = brachial DBP by oscillometric device; FW = forward wave amplitude; MAP = mean arterial pressure; PA-1 = apparent peripheral amplification; PA-2 = true peripheral amplification; PP = pulse pressure; PP-osc = brachial PP by oscillometric device; RW = reflected wave amplitude; RWTT = reflected wave transit time; SBP = systolic blood pressure; SBP-osc = brachial SBP by oscillometric device; 1/CF-PWV = inverse of CF-PWV.

Candidate gene analyses
-----------------------

GEE and FBAT additive genetic effect models were run for SNPs in or near 6 genes in the renin-angiotensin-aldosterone pathways. These genes were selected a priori because of a substantial body of literature implicating them in hypertension and altered vascular properties. All SNPs from 200 Kb proximal to the start and extending to 200 kb of the terminus of each gene were included in analysis providing the minor allele frequency was \>= 0.1, the genotype call rate was 0.8, and the Hardy-Weinberg equilibrium p value was \>= 0.001.

Results
=======

The six primary BP phenotypes were examination 1 SBP and DBP (n = 1260), examination 7 SBP and DBP (n = 1233), and long-term averaged SBP and DBP (n = 1327). The five primary arterial stiffness phenotypes were carotid-femoral and carotid-brachial pulse wave velocity, forward and reflected pressure wave amplitude, and mean arterial pressure (n = 644). The study sample available for BP phenotypes included up to 1327 individuals (mean age 52 years, 54% women for the long-term SBP and DBP phenotypes). The complete list of blood pressure and arterial stiffness phenotypes analyzed and the covariates used in generating sex-specific standardized residuals for each phenotype are listed in Table [1](#T1){ref-type="table"}. Full disclosure of all GEE and FBAT associations for the traits listed in Table [1](#T1){ref-type="table"} can be found at the National Center for Biotechnology Information dbGaP website: <http://web.ncbi.nlm.nih.gov/projects/gap/framingham/cgi-bin/study.cgi?id=phs000007>.

Results of primary GEE models for an additive genetic effect for DBP, SBP, and arterial stiffness phenotypes are presented in Table [2a](#T2){ref-type="table"}. None of the association results attained genome-wide significance. The lowest p values for DBP, SBP, and arterial stiffness phenotypes, respectively, were rs1963982 (p = 3.31 × 10^-6^), rs10493340 (p = 1.7 × 10^-6^), and rs6063312 (p = 2.1 × 10^-6^for reflected wave amplitude). For the same three phenotype groups the number of associations with p values \< 10^-5^were 6, 1, and 5, respectively.

###### 

Results of GEE and FBAT Additive Genetic Effects: Association, Linkage, and Heritability of Blood Pressure and Arterial Stiffness Phenotypes

  **2a. Results of GEE Additive Genetic Effects Models**                                                                                                                     
  -------------------------------------------------------------------------- ---------- ------------------ ---------- -------------- ------------------- ------------------- -------------------------
  **Phenotype**                                                              **Exam**   **SNP**            **Chr.**   **Position**   **GEE P value**     **FBAT P value**    **Gene**
                                                                                                                                                                             
  **Diastolic Blood Pressure**                                                                                                                                               
                                                                                                                                                                             
  DBP                                                                        7          rs1963982          8          73,269,470     **3.31 × 10^-6^**   0.002               
  DBP                                                                        1          rs935334           14         75,683,431     **3.32 × 10^-6^**   0.002               
  DBP                                                                        7          rs4370013          3          2,629,691      **3.73 × 10^-6^**   0.032               CNTN4
  DBP                                                                        7          rs10491334         5          110,800,303    **4.47 × 10^-6^**   0.133               CAMK4
  DBP                                                                        1          rs2121070          14         75,720,517     **4.88 × 10^-6^**   0.02                C14orf118
  DBP                                                                        1          rs2509458          6          88,709,299     **6.94 × 10^-6^**   0.001               
  DBP                                                                        7          rs6950982          7          100,360,038    **1.22 × 10^-5^**   0.036               TRIM56, SERPINE1, AP1S1
  DBP                                                                        7          rs10510911         3          63,678,681     **1.65 × 10^-5^**   0.021               
  DBP                                                                        1          rs1816088          5          39,897,583     **1.73 × 10^-5^**   0.012               
  DBP                                                                        7          rs1519592          6          140,585,329    **1.89 × 10^-5^**   2.83 × 10^-4^       
                                                                                                                                                                             
  **Systolic Blood Pressure**                                                                                                                                                
                                                                                                                                                                             
  SBP                                                                        1          rs10493340         1          63,303,150     **1.69 × 10^-6^**   0.13                
  SBP                                                                        7          rs1841055          4          70,039,785     **2.07 × 10^-5^**   0.003               UGT2A3
  SBP                                                                        1          rs2035254          3          107,292,420    **2.20 × 10^-5^**   0.046               
  SBP                                                                        1--7       rs1408263          6          18,515,722     **2.43 × 10^-5^**   0.121               IBRDC2
  SBP                                                                        7          rs1408113          9          113,822,387    **2.54 × 10^-5^**   0.034               ZNF618
  SBP                                                                        7          rs629448           9          26,263,322     **3.14 × 10^-5^**   0.011               
  SBP                                                                        7          rs10485320         6          47,884,860     **3.28 × 10^-5^**   0.012               OPN5
  SBP                                                                        7          rs10512889         5          6,921,922      **4.17 × 10^-5^**   0.008               
  SBP                                                                        1          rs1328925          4          159,547,895    **4.32 × 10^-5^**   0.118               TMEM144
  SBP                                                                        7          rs9321764          6          140,532,157    **4.39 × 10^-5^**   4.76 × 10^-4^       
                                                                                                                                                                             
  **Tonometry Phenotypes**                                                                                                                                                   
                                                                                                                                                                             
  RW                                                                         7          rs6063312          20         46,776,466     **2.09 × 10^-6^**   0.063               PREX1
  CB-PWV                                                                     7          rs770189           5          88,124,195     **2.53 × 10^-6^**   0.005               MEF2C
  CB-PWV                                                                     7          rs10514688         3          34,937,673     **5.66 × 10^-6^**   0.027               
  CB-PWV                                                                     7          rs7042864          9          107,951,862    **6.13 × 10^-6^**   0.077               
  MAP                                                                        7          rs1322512          6          153,040,067    **7.76 × 10^-6^**   0.038               SYNE1
  FW                                                                         7          rs348384           19         6,503,386      **1.16 × 10^-5^**   0.058               TUBB4, TNFSF9, TNFSF7
  RW                                                                         7          rs10507514         13         42,132,814     **1.28 × 10^-5^**   0.066               TNFSF11
  FW                                                                         7          rs3793427          8          17,188,201     **1.43 × 10^-5^**   0.059               VPS37A
  RW                                                                         7          rs10506928         12         85,003,844     **1.62 × 10^-5^**   0.021               
  FW                                                                         7          rs4075701          2          116,146,020    **1.63 × 10^-5^**   0.025               
  RW                                                                         7          rs11784583         8          103,154,213    **3.83 × 10^-5^**   0.036               
  RW                                                                         7          rs10513957         18         65,039,417     **4.15 × 10^-5^**   0.019               
  CF-PWV                                                                     7          rs10506440         12         60,993,853     **4.18 × 10^-5^**   0.064               USP15
  RW                                                                         7          rs1197850          13         34,828,744     **4.57 × 10^-5^**   0.042               
                                                                                                                                                                             
  **2b. Results of FBAT Additive Genetic Effects Models**                                                                                                                    
                                                                                                                                                                             
  **Phenotype**                                                              **Exam**   **SNP**            **Chr.**   **Position**   **GEE P value**     **FBAT P Value**    **Gene**
                                                                                                                                                                             
  DBP                                                                        1          rs1590919          13         104,000,000    0.079               **1.42 × 10^-6^**   
  DBP                                                                        1--7       rs636864           6          150,000,000    4.49 × 10^-4^       **1.55 × 10^-6^**   
  DBP                                                                        1          rs726698           2          35,366,992     0.02                **1.15 × 10^-5^**   
  DBP                                                                        7          rs1338657          6          103,000,000    0.001               **2.57 × 10^-5^**   
  DBP                                                                        1--7       rs10506595         12         69,191,621     0.133               **3.40 × 10^-5^**   PTPRB
  DBP                                                                        7          rs9311171          3          37,971,481     0.025               **4.03 × 10^-5^**   CTDSPL
  DBP                                                                        1          rs10520569         15         82,520,393     0.577               **4.24 × 10^-5^**   ADAMTSL3
  DBP                                                                        7          rs4514016          8          120,000,000    3.70 × 10^-5^       **4.52 × 10^-5^**   SAMD12
  DBP                                                                        7          rs2322509          8          27,052,291     0.172               **4.91 × 10^-5^**   
  DBP                                                                        1--7       rs10504389         8          66,718,741     0.1                 **5.53 × 10^-5^**   ARMC1, MTFR1
                                                                                                                                                                             
  SBP                                                                        1          rs1588260          5          121,000,000    0.001               **3.43 × 10^-6^**   
  SBP                                                                        1          rs726698           2          35,366,992     0.023               **2.70 × 10^-5^**   
  SBP                                                                        7          rs963328           1          209,000,000    0.036               **3.01 × 10^-5^**   
  SBP                                                                        7          rs729053           18         50,960,679     0.008               **3.41 × 10^-5^**   
  SBP                                                                        7          rs1434939          8          69,666,816     0.004               **4.97 × 10^-5^**   
  SBP                                                                        1--7       rs10498500         14         62,030,261     0.005               **6.25 × 10^-5^**   
  SBP                                                                        1          rs3853241          5          166,000,000    0.003               **6.25 × 10^-5^**   
  SBP                                                                        1--7       rs1590919          13         104,000,000    0.14                **6.66 × 10^-5^**   
  SBP                                                                        1          rs6763833          3          65,953,132     0.374               **8.18 × 10^-5^**   MAGI1
  SBP                                                                        7          rs6940110          6          10,377,050     0.145               **8.42 × 10^-5^**   
                                                                                                                                                                             
  FW                                                                         7          rs1539377          9          81,441,976     5.48 × 10^-5^       **5.26 × 10^-6^**   TLE1
  RW                                                                         7          rs792833           3          101,000,000    0.123               **6.01 × 10^-6^**   COL8A1
  MAP                                                                        7          rs10495191         1          219,000,000    0.007               **1.46 × 10^-5^**   TAF1A
  CB-PWV                                                                     7          rs10494786         1          196,000,000    0.079               **1.56 × 10^-5^**   
  CB-PWV                                                                     7          rs2160595          18         61,742,129     0.001               **2.38 × 10^-5^**   CDH7
  FW                                                                         7          rs28899            5          82,798,839     0.001               **2.99 × 10^-5^**   VCAN
  CF-PWV                                                                     7          rs1349721          4          86,693,958     0.105               **3.34 × 10^-5^**   ARHGAP24
  CB-PWV                                                                     7          rs3001450          9          93,164,925     0.61                **3.91 × 10^-5^**   WNK2
  CB-PWV                                                                     7          rs1389608          14         46,027,527     0.111               **4.08 × 10^-5^**   
  RW                                                                         7          rs10499221         6          141,000,000    0.003               **5.92 × 10^-5^**   
                                                                                                                                                                             
  **2c. Linkage Results**                                                                                                                                                    
                                                                                                                                                                             
  **Phenotype**                                                              **Exam**   **LOD**            **Chr.**   **Position**   **Lower bound\***   **Upper bound**     
                                                                                                                                                                             
  DBP                                                                        1--7       2.03               17         12,245,760     9,173,838           16,450,642          
                                                                                                                                                                             
  SBP                                                                        1--7       3                  15         100,152,332    97,636,843          100,152,332         
  SBP                                                                        7          2.55               15         79,161,506     75,509,164          85,958,968          
  SBP                                                                        7          2.39               3          129,657,137    105,768,506         141,888,352         
  SBP                                                                        1--7       2.18               5          41,710,612     36,665,015          67,696,396          
  SBP                                                                        1--7       2.07               3          107,844,505    99,203,989          144,119,612         
  SBP                                                                        7          2.06               12         101,785,625    94,922,502          107,253,596         
                                                                                                                                                                             
  RW                                                                         7          5.02               8          19,102,897     17,257,073          21,506,898          
  RW                                                                         7          3.35               9          10,499,434     6,759,229           10,671,522          
  RW                                                                         7          3.17               4          169,091,021    162,723,480         170,955,956         
  CF-PWV                                                                     7          3.04               2          74,021,676     49,795,460          103,043,940         
  CF-PWV                                                                     7          2.68               18         40,229,747     38,788,852          43,206,229          
  FW                                                                         7          2.47               3          60,298,724     24,621,158          62,757,508          
  RW                                                                         7          2.47               15         100,152,332    94,749,239          100,152,332         
  CF-PWV                                                                     7          2.43               15         99,551,603     92,469,518          100,152,332         
  RW                                                                         7          2.29               1          12,153,078     4,266,833           17,528,974          
  CF-PWV                                                                     7          2.17               4          11,998,283     7,901,357           25,777,055          
                                                                                                                                                                             
  **2d. Heritability of Blood Pressure and Arterial Stiffness Phenotypes**                                                                                                   
                                                                                                                                                                             
  **Phenotype**                                                              **Exam**   **Heritability**   **s.e.**                                                          
                                                                                                                                                                             
  DBP                                                                        1          0.3                0.04                                                              
  DBP                                                                        7          0.35               0.06                                                              
  DBP                                                                        1--7       0.55               0.05                                                              
                                                                                                                                                                             
  SBP                                                                        1          0.28               0.04                                                              
  SBP                                                                        7          0.45               0.06                                                              
  SBP                                                                        1--7       0.57               0.04                                                              
                                                                                                                                                                             
  CB-PWV                                                                     7          0.02               0.09                                                              
  CF-PWV                                                                     7          0.43               0.1                                                               
  FW                                                                         7          0.22               0.09                                                              
  MAP                                                                        7          0.32               0.1                                                               
  RW                                                                         7          0.66               0.1                                                               

Association results based on minor allele frequency \>= 0.1, HWE p value \>= 0.001, call rate \>= 0.8

CB-PWV = carotid-brachial pulse wave velocity; CF-PWV = carotid-femoral pulse wave velocity; DBP = diastolic blood pressure; FW = forward wave amplitude; MAP = mean arterial pressure; RW = reflected wave amplitude; SBP = systolic blood pressure

\*Lower and upper bounds for LOD-1.5 interval.

FBAT models for an additive genetic effect are presented in Table [2b](#T2){ref-type="table"}. Two SNPs for DBP and one for SBP yielded p values \< 10^-5^. Of note, rs10520569 in *ADAMTSL3*was associated with DBP (4.2 × 10^-5^) and SBP (1.4 × 10^-4^). For arterial stiffness phenotypes there were 2 p values \< 10^-5^, including rs792833 in *COL8A1*.

Linkage analyses (Table [2c](#T2){ref-type="table"}) yielded a LOD score of 3 for long-term SBP on chromosome 15 at 100 Mb. Several tonometry linkage peaks exceeded a LOD score of 3, including a LOD of 5.0 for reflected wave (chromosome 8 at 19 Mb). Heritability estimates (Table [2d](#T2){ref-type="table"}) were high for long-term average DBP (h^2^= 0.55) and SBP (h^2^= 0.57), and intermediate for the other BP phenotypes (h^2^= 0.28--0.45). Among the arterial stiffness phenotypes, heritability was high for the reflected arterial waveform (h^2^= 0.66), low for carotid-brachial PWV (h^2^= 0.02), and intermediate for the other phenotypes (h^2^= 0.22--0.43). These heritability results are consistent with our prior findings \[[@B6],[@B7]\].

Secondary analyses using the GEE general genetic effects model (2 degrees of freedom; more sensitive in detecting recessive effects) are presented in Table [3](#T3){ref-type="table"}. The lowest p value for long-term DBP was in *CCL20*(rs7591163, p = 2.3 × 10^-7^) and for SBP was in *CDH13*(rs3096277, p = 9.9 × 10^-8^). Of note, SNPs in *CDH13*, CCL20, and *WDR69*were associated with DBP and SBP. GEE general effects models for the tonometry phenotypes identified association of mean arterial pressure with *TGFBR2*(rs3773643, p = 2 × 10^-7^).

###### 

Results of GEE General Genetic Effects Model for Long-term Average Blood Pressure Phenotypes and Arterial Stiffness

  **Phenotype**                                      **SNP**      **Chr.**   **Position**   **P value\***   **Gene**
  -------------------------------------------------- ------------ ---------- -------------- --------------- ----------------
  **Diastolic Blood Pressure (long-term average)**                                                          
                                                                                                            
  DBP                                                rs7591163    2          228,423,620    2.90 × 10^-7^   CCL20, WDR69
  DBP                                                rs1901167    5          40,996,921     6.40 × 10^-5^   C7
  DBP                                                rs6829806    4          85,916,019     8.10 × 10^-5^   CDS1
  DBP                                                rs6796000    3          189,874,213    1.10 × 10^-4^   LPP
  DBP                                                rs3096277    16         82,321,705     1.40 × 10^-4^   CDH13
  DBP                                                rs969049     4          99,346,035     1.40 × 10^-4^   
  DBP                                                rs10503497   8          14,326,753     1.40 × 10^-4^   SGCZ
  DBP                                                rs2262138    19         16,213,403     2.10 × 10^-4^   FAM32A, AP1M1
  DBP                                                rs10509333   10         72,737,658     3.70 × 10^-4^   UNC5B, SLC29A3
  DBP                                                rs933296     12         109,837,230    4.10 × 10^-4^   MYL2
                                                                                                            
  **Systolic Blood Pressure (long-term average)**                                                           
                                                                                                            
  SBP                                                rs3096277    16         82,321,705     9.90 × 10^-8^   CDH13
  SBP                                                rs1721359    2          228,460,118    1.00 × 10^-5^   CCL20, WDR69
  SBP                                                rs225942     14         29,595,139     5.30 × 10^-5^   PRKD1
  SBP                                                rs298988     4          119,867,850    7.80 × 10^-5^   SEC24D
  SBP                                                rs10514096   5          76,700,940     1.10 × 10^-4^   PDE8B
  SBP                                                rs10512245   9          95,771,366     1.40 × 10^-4^   
  SBP                                                rs294593     5          163,000,000    1.80 × 10^-4^   MAT2B
  SBP                                                rs6085660    20         6,639,069      1.90 × 10^-4^   BMP2
  SBP                                                rs6796000    3          190,000,000    2.20 × 10^-4^   LPP
  SBP                                                rs575121     12         117,000,000    2.20 × 10^-4^   TAOK3
                                                                                                            
  **Tonometry**                                                                                             
                                                                                                            
  MAP                                                rs3773643    3          30,685,247     1.99 × 10^-7^   TGFBR2
  FW                                                 rs3793427    8          17,188,201     1.96 × 10^-6^   VPS37A
  RW                                                 rs6492654    13         92,688,671     2.28 × 10^-6^   GPC6
  CF-PWV                                             rs1367248    2          124,734,834    2.88 × 10^-6^   CNTNAP5
  CF-PWV                                             rs10521232   17         13,480,529     3.88 × 10^-6^   HS3ST3A1
  FW                                                 rs3766680    1          173,563,0070   4.15 × 10^-6^   TNR
  RW                                                 rs1371924    3          144,732,760    4.44 × 10^-6^   SLC9A9
  RW                                                 rs10488172   7          132,985,716    8.49 × 10^-6^   EXOC4
  FW                                                 rs10507534   13         44,724,220     1.05 × 10^-5^   GTF2F2
  FW                                                 rs719856     6          47,702,681     1.21 × 10^-5^   CD2AP

\*P values from 2 degree of freedom test

CB-PWV = carotid-brachial pulse wave velocity; CF-PWV = carotid-femoral pulse wave velocity; DBP = diastolic blood pressure; FW = forward wave amplitude; MAP = mean arterial pressure; RW = reflected wave amplitude; SBP = systolic blood pressure

Minor allele frequency \>= 0.20, HWE P value \>= 0.05, call rate \>= 0.80

Geometric means of GEE association results (additive genetic effect model) for SBP and DBP considered jointly are summarized in Table [4](#T4){ref-type="table"}. The lowest p values were noted for Examination 1 BP values (rs10493340, p = 1.5 × 10^-5^). Geometric means of association results for the 5 tonometry phenotypes considered concurrently yielded its lowest p value (rs10518082, p = 0.002) for *DCK*.

###### 

Top Results for Geometric Means of SBP and DBP Considered Jointly (at examinations 1, 7 and in the long term), and arterial stiffness phenotypes considered jointly.

  **SNP**                  **Exam**   **Chr.**   **Position**   **P value**     **Gene**
  ------------------------ ---------- ---------- -------------- --------------- -----------
  **DBP and SBP**                                                               
                                                                                
  rs10493340               1          1          63,303,150     1.49 × 10^-5^   
  rs9321764                7          6          140,532,157    2.89 × 10^-5^   
  rs10491334               7          5          110,800,303    3.74 × 10^-5^   CAMK4
  rs2121070                1          14         75,720,517     3.96 × 10^-5^   C14orf118
  rs1328925                1          4          159,547,895    4.22 × 10^-5^   TMEM144
  rs10510079               1          10         122,473,101    7.27 × 10^-5^   
  rs7562854                7          2          12,149,816     7.52 × 10^-5^   
  rs1841055                7          4          70,039,785     7.63 × 10^-5^   UGT2A3
  rs10485320               7          6          47,884,860     7.75 × 10^-5^   OPN5
  rs9298203                7          8          73,270,276     8.28 × 10^-5^   
                                                                                
  **Arterial stiffness**                                                        
                                                                                
  rs10518082               7          4          72,282,885     0.002           DCK
  rs1322512                7          6          153,040,067    0.005           SYNE1
  rs10511389               7          3          120,557,547    0.007           CDGAP
  rs883524                 7          8          23,250,536     0.008           LOXL2
  rs965674                 7          5          82,518,340     0.008           XRCC4
  rs10502173               7          11         112,708,233    0.009           TTC12
  rs1468512                7          17         64,731,363     0.010           ABCA10
  rs4075701                7          2          116,146,020    0.011           
  rs10496604               7          2          123,501,987    0.011           
  rs770189                 7          5          88,124,195     0.011           MEF2C

Based on Additive genetic effects model using GEE and minor allele frequency of 0.1, call rate \>= 0.80 and HWE p value \>= 0.001

SNPs in 6 renin-angiotensin-aldosterone pathway genes were analyzed for association with the BP and tonometry phenotypes (Table [5](#T5){ref-type="table"}). A total of 69 SNPs qualified for analysis (minor allele frequency \>= 0.1, Hardy Weinberg equilibrium p \>= 0.001, call rate \>= 0.8). For the primary traits there were few associations from GEE models for an additive genetic effect with p values \< 0.05 and none with p \< 0.001.

###### 

Results for Pre-Specified Candidate Genes

  **Candidate gene**             **Total number of SNPs\***   **SNPs with p value \< 0.05**   **Phenotype**   **GEE p value**   **FBAT p value**
  ------------------------------ ---------------------------- ------------------------------- --------------- ----------------- ------------------
  **Diastolic blood pressure**                                                                                                  
                                                                                                                                
  ACE                            3                            0                                                                 
  AGT                            13                           rs2478518                                       0.021             0.186
  AGTR1                          17                           0                                                                 
  CYP11B2                        1                            0                                                                 
  NR3C2                          26                           rs6845733                                       0.008             0.399
  REN                            9                            0                                                                 
                                                                                                                                
  **Systolic blood pressure**                                                                                                   
                                                                                                                                
  ACE                            3                            0                                                                 
  AGT                            13                           rs2478518                                       0.003             0.275
  AGTR1                          17                           0                                                                 
  CYP11B2                        1                            0                                                                 
  NR3C2                          26                           rs6845733                                       0.010             0.323
                                                              rs3916013                                       0.024             0.598
  REN                            9                            0                                                                 
                                                                                                                                
  **Arterial stiffness**                                                                                                        
                                                                                                                                
  ACE                            3                            0                                                                 
  AGT                            13                           rs731824                        MAP             0.022             0.397
                                                              rs2478518                       FW              0.024             0.688
                                                              rs2478516                       FW              0.037             0.217
                                                              rs2478516                       RW              0.046             0.663
  AGTR1                          17                           rs1059502                       MAP             0.025             0.023
                                                              rs427832                        FW              0.046             0.963
  CYP11B2                        1                            rs2717594                       CF-PWV          0.003             0.308
  NR3C2                          26                           rs3910046                       CF-PWV          0.009             0.383
                                                              rs9307847                       CB-PWV          0.011             0.741
                                                              rs3910046                       CB-PWV          0.014             0.409
                                                              rs10519959                      CB-PWV          0.018             0.175
                                                              rs3846317                       RW              0.021             0.649
                                                              rs4835136                       CB-PWV          0.027             0.268
                                                              rs3846318                       RW              0.042             0.293
                                                              rs10519958                      RW              0.049             0.529
  REN                            9                            rs16776                         FW              0.012             0.115
                                                              rs3911890                       FW              0.022             0.207

\*Includes all SNPs within 200 kb of start to 200 kb beyond end of gene, with genotype call rate \>= 0.8; minor allele frequency \>= 0.1; HWE p \>= 0.001

CB-PWV = carotid-brachial pulse wave velocity; CF-PWV = carotid-femoral pulse wave velocity; DBP = diastolic blood pressure; FW = forward wave amplitude; MAP = mean arterial pressure; RW = reflected wave amplitude; SBP = systolic blood pressure

Discussion and conclusion
=========================

We provide results of genome-wide association study for 6 blood pressure and 5 arterial stiffness phenotypes in a carefully characterized study sample. Association analyses and linkage reveal a number of intriguing results. For the GEE model of additive genetic effects (Table [2a](#T2){ref-type="table"}) there were 7 SNPs with p values \< 10^-5^for blood pressure and 5 for arterial stiffness phenotypes. Among the GEE additive effect model results the most likely candidate genes were MEF2C, SYNE1, and TNFSF11, which were associated with arterial stiffness. We have not yet attempted replication of our results. Follow-up genotyping of the top SBP and DBP SNPs reported in our study sample in additional Framingham participants is planned; additional replication attempts will be needed in independent samples to confirm any of the association results we report.

FBAT (Table [2b](#T2){ref-type="table"}) identified association of *COL8A1*with arterial stiffness (p value 6 × 10^-6^for rs792833). This gene codes for type VIII collagen, which is produced by aortic endothelial cells \[[@B17]\], suggesting a biologically plausible association.

Linkage yielded a LOD score of 3, approaching genome-wide significance, for long-term SBP on chromosome 15. A meta-analysis of blood pressure and hypertension linkage studies did not identify this as a region of interest \[[@B9]\]. The lower LOD scores for long-term SBP on chromosome 17 (\~67 cM) in this investigation compared with our prior findings \[[@B6]\] appears to be largely due to differences in phenotype definition of long-term SBP with the exclusion of early examination BP values in the original cohort participants and the inclusion of offspring cohort examination 7 blood pressures in this analysis. When linkage analyses were repeated with the inclusion of the early original cohort exams using the prior phenotype definitions, the same linkage peak on chromosome 17 emerged (LOD \> 4).

For tonometry phenotypes, we found LOD scores for reflected wave amplitude of 5.0 (chromosome 8 at 19 Mb) and 3.2 (chromosome 4, 169 Mb) near peaks for this phenotype that we previously reported in a largely overlapping study sample \[[@B7]\]. Similarly, we once again identified a linkage peak for carotid-femoral pulse wave velocity (LOD 3.0; chromosome 2 at 74 mb).

Compared with the primary GEE model for additive genetic effects (Table [2a](#T2){ref-type="table"}), a different set of SNPs was identified in secondary GEE general effects models (Table [3](#T3){ref-type="table"}) for long-term DBP and SBP, including 2 SNPs with p values \< 10^-6^. Differences in model results may be due to the greater sensitivity of the general model to detect recessive genotype effects. SNPs in *CCL20*, *CDH13*, and *LPP*were associated with both long-term SBP and DBP. GEE general genetic effects models for arterial stiffness phenotypes yielded the lowest p value (p = 1.99 × 10^-7^) for rs3773643 in *TGFBR2*, which has been implicated in aortic aneurysm and Loeys-Dietz syndrome \[[@B18],[@B19]\]. Disruption of the aortic wall would be expected to affect arterial stiffness.

Due to high correlations of SBP and DBP (within examination r = 0.77; long-term r = 0.82), joint analyses of SBP and DBP added little to what was identified in individual phenotype analyses. In contrast, joint analyses of the five tonometry phenotypes, which are less highly correlated, identified *LOXL2*, *SYNE1*, and *MEF2C*as attractive candidates. *LOXL2*is a member of the lysyl oxidase family of enzymes that initiate cross-linking of collagens and elastin, and alter arterial elasticity \[[@B20]\]. Collagen and elastin cross-links are critical to tensile strength of the extracellular matrix. Mice null for lysyl oxidase (*LOX*) die perinatally from aortic aneurysm \[[@B21]\]. *MEF2C*is involved in cardiac morphogenesis and extracellular matrix remodeling \[[@B22]\]. *SYNE1*is involved in aortic vascular smooth muscle differentiation \[[@B23]\]. To our knowledge, genetic variation in these genes has not previously been shown to be associated with alterations in arterial properties in humans. Whether our results provide nominal evidence of such association or merely chance findings remains to be determined.

Since none of the primary associations attained genome-wide significance, this investigation should be viewed as hypothesis generating. Association analyses for SNPs in six renin-angiotensin-aldosterone pathway genes showed weak evidence of association. Negative results for these candidate genes may be due in part to incomplete linkage disequilibrium coverage of these genes by the SNPs in this genome-wide scan. It is likely that the vast majority of low p values from association analyses are due to chance. Replication studies in other populations, using a genome-wide approach or selective genotyping is needed to establish if any of our results are indicative of true positive associations.

We provide results of genome-wide association testing for blood pressure and arterial stiffness phenotypes obtained in a carefully described community-based sample of adults who were recruited without regard to disease status. Additional studies are needed to validate these results. Finding genetic variants associated with hypertension or altered arterial properties may aid in the identification of high risk individuals and in the development of new targeted therapies for hypertension. Our report is one of the earlier genome-wide association studies of blood pressure. Several additional studies, some with larger sample size and others with more dense genome-wide coverage of common variation will follow. In that regard, a 550 k SNP genome-wide association study in approximately 9400 Framingham Heart Study participants across three generations is underway and results from that study will help in the interpretation of the findings we report in this manuscript.
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